Dr. Lamont Tyler serves as medical director of specialty physician services at OSF St. Joseph Medical Center in Illinois. Outside of work, Dr. Lamont Tyler provides support to a number of medically engaged organizations, including the American Diabetes Association (ADA). At the recent ADA 76th Scientific Session in New Orleans, a unique bionic pancreas was unveiled.
The artificial pancreas delivers glucagon through small doses using an automated continuous glucose monitoring system to significantly reduce the chances of hypoglycemia in patients who have type 1 diabetes. Glucagon, normally produced and secreted by the pancreas, raises blood glucose and helps maintain appropriate levels in concert with insulin, which lowers blood glucose.
A double blind, placebo-controlled, and randomized crossover study involving 22 patients using an insulin pump or daily injections found that use of the bionic pancreas reduced instances of hypoglycemia. Patients received either glucagon or placebo on alternative days and had no knowledge of which they received. Researchers found that half as many symptomatic hypoglycemic incidents happened on glucagon days when compared to placebo days.
As Medical Director of OSF St. Joseph Medical Center’s PromptCare, Dr. Lamont Tyler takes pride in the diverse array of services offered to all individuals on a walk-in basis.